Patient Corner

Anatomical Illustrations

More

Last reference updates

  • Jan 17, 2018 - MedWatch Drug Updates

FDA Safety Alert - Becton-Dickinson replaced problematic rubber stoppers in its syringes

FDA notifies that Becton-Dickinson replaced problematic rubber stoppers associated with loss of drug potency

  • Dec 20, 2017 - MedWatch Drug Updates

Class I Recall of Defibrillation Electrodes by Physio-Control: Artwork shows incorrect placement instruction for infants

Incorrect placement of electrodes may result in failure to deliver an effective shock to an infant with cardiac arrest.

  • Jan 3, 2018 - MedWatch Drug Updates

Recall of Compounded Sterile Products by PharMEDium Services due to lack of sterility assurance

PharMEDium Services has recalled sterile products due to lack of sterility assurance which may cause life-threatening infections.

  • Dec 20, 2017 - MedWatch Drug Updates

FDA warning: Gadolinium retention in patients body after receiving gadolinium-based contrast agents (GBCAs)

FDA has concluded that the benefit of all approved GBCAs continues to outweigh any potential risks.

  • Dec 6, 2017 - MedWatch Drug Updates

Recall of pharmacist choice alcohol prep pads by simple diagnostics due to quality concerns.

Simple Diagnostics has recalled alcohol prep pads due to lack of sterility assurance and other quality issues.

  • Nov 7, 2017 - MedWatch Drug Updates

Voluntary field action for Infant/Child Reduced Energy Defibrillation Electrodes by Cardinal Health

Voluntary field action for Infant/Child Reduced Energy Defibrillation Electrodes by Cardinal Health due to incorrect electrode placement.

  • Oct 23, 2017 - MedWatch Drug Updates

Recall of injectable products by SCA Pharmaceuticals: Products may contain microbial contamination

Recall of injectables by SCA Pharmaceuticals due to microbial contamination which may cause serious adverse events and life-threatening infections.

  • Mar 11, 2016 - MedWatch Drug Updates

Safety alert against the use of Human and Animal Sterile Drug Products by I.V. Specialty-Lack of sterility assurance

FDA is alerting not to use Human and Animal Drug Products intended to be sterile that are produced and distributed by I.V. Specialty Ltd. due to lack of sterility assurance

  • Apr 28, 2017 - FDA Drug Updates

FDA approved Brineura (cerliponase alfa) for Batten disease

Brineura (cerliponase alfa) is approved as first therapy for a specific form of Batten disease

  • Apr 25, 2017 - MedWatch Drug Updates

Recall of 25% Dextrose Injection, USP, (Infant) by Hospira- Presence of particulate matter

Recall of 25% Dextrose Injection, USP, (Infant) by Hospira due to the presence of particulate matter identified as human hair